157 related articles for article (PubMed ID: 38235705)
21. Feasibility of quantifying
Oh TJ; Oh HI; Seo YY; Jeong D; Kim C; Kang HW; Han YD; Chung HC; Kim NK; An S
Clin Epigenetics; 2017; 9():126. PubMed ID: 29225717
[TBL] [Abstract][Full Text] [Related]
22. JMJD2C promotes colorectal cancer metastasis via regulating histone methylation of MALAT1 promoter and enhancing β-catenin signaling pathway.
Wu X; Li R; Song Q; Zhang C; Jia R; Han Z; Zhou L; Sui H; Liu X; Zhu H; Yang L; Wang Y; Ji Q; Li Q
J Exp Clin Cancer Res; 2019 Oct; 38(1):435. PubMed ID: 31665047
[TBL] [Abstract][Full Text] [Related]
23. Methylation of
Li H; Yang W; Zhang M; He T; Zhou F; G Herman J; Hu L; Guo M
Epigenomics; 2021 Sep; 13(17):1403-1419. PubMed ID: 34558311
[TBL] [Abstract][Full Text] [Related]
24. Usefulness of plasma epigenetic changes of five major genes involved in the pathogenesis of colorectal cancer.
Pack SC; Kim HR; Lim SW; Kim HY; Ko JY; Lee KS; Hwang D; Park SI; Kang H; Park SW; Hong GY; Hwang SM; Shin MG; Lee S
Int J Colorectal Dis; 2013 Jan; 28(1):139-47. PubMed ID: 22990173
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of GLYR1 contributes to microsatellite instability colorectal cancer by targeting p21 via the p38MAPK and PI3K/AKT pathways.
Hu Z; Long T; Ma Y; Zhu J; Gao L; Zhong Y; Wang X; Wang X; Li Z
J Exp Clin Cancer Res; 2020 May; 39(1):76. PubMed ID: 32370786
[TBL] [Abstract][Full Text] [Related]
26. Knockdown of GRHL2 inhibited proliferation and induced apoptosis of colorectal cancer by suppressing the PI3K/Akt pathway.
Hu F; He Z; Sun C; Rong D
Gene; 2019 Jun; 700():96-104. PubMed ID: 30917932
[TBL] [Abstract][Full Text] [Related]
27. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway.
Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655
[TBL] [Abstract][Full Text] [Related]
28. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
[TBL] [Abstract][Full Text] [Related]
29. Promoter hypermethylation of RASSF1A, MGMT, and HIC-1 genes in benign and malignant colorectal tumors.
Abouzeid HE; Kassem AM; Abdel Wahab AH; El-mezayen HA; Sharad H; Abdel Rahman S
Tumour Biol; 2011 Oct; 32(5):845-52. PubMed ID: 21274674
[TBL] [Abstract][Full Text] [Related]
30. COPS5 and LASP1 synergistically interact to downregulate 14-3-3σ expression and promote colorectal cancer progression via activating PI3K/AKT pathway.
Zhou R; Shao Z; Liu J; Zhan W; Gao Q; Pan Z; Wu L; Xu L; Ding Y; Zhao L
Int J Cancer; 2018 May; 142(9):1853-1864. PubMed ID: 29226323
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic silencing of NTSR1 is associated with lateral and noninvasive growth of colorectal tumors.
Kamimae S; Yamamoto E; Kai M; Niinuma T; Yamano HO; Nojima M; Yoshikawa K; Kimura T; Takagi R; Harada E; Harada T; Maruyama R; Sasaki Y; Tokino T; Shinomura Y; Sugai T; Imai K; Suzuki H
Oncotarget; 2015 Oct; 6(30):29975-90. PubMed ID: 26334593
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA-SNHG7 acts as a target of miR-34a to increase GALNT7 level and regulate PI3K/Akt/mTOR pathway in colorectal cancer progression.
Li Y; Zeng C; Hu J; Pan Y; Shan Y; Liu B; Jia L
J Hematol Oncol; 2018 Jul; 11(1):89. PubMed ID: 29970122
[TBL] [Abstract][Full Text] [Related]
33. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X
Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539
[TBL] [Abstract][Full Text] [Related]
34. DNA methylation patterns in blood of patients with colorectal cancer and adenomatous colorectal polyps.
Cassinotti E; Melson J; Liggett T; Melnikov A; Yi Q; Replogle C; Mobarhan S; Boni L; Segato S; Levenson V
Int J Cancer; 2012 Sep; 131(5):1153-7. PubMed ID: 22020530
[TBL] [Abstract][Full Text] [Related]
35. Silencing or inhibition of H3K79 methyltransferase DOT1L induces cell cycle arrest by epigenetically modulating c-Myc expression in colorectal cancer.
Yang L; Lei Q; Li L; Yang J; Dong Z; Cui H
Clin Epigenetics; 2019 Dec; 11(1):199. PubMed ID: 31888761
[TBL] [Abstract][Full Text] [Related]
36. KISS1 methylation and expression as predictors of disease progression in colorectal cancer patients.
Chen SQ; Chen ZH; Lin SY; Dai QB; Fu LX; Chen RQ
World J Gastroenterol; 2014 Aug; 20(29):10071-81. PubMed ID: 25110434
[TBL] [Abstract][Full Text] [Related]
37. KCNE4 expression is correlated with the pathological characteristics of colorectal cancer patients and associated with the radioresistance of cancer cells.
Tian K; Tao Z; Chen Y; Du J; Chen M; Wang D; Li Z
Pathol Res Pract; 2023 Jan; 241():154234. PubMed ID: 36459833
[TBL] [Abstract][Full Text] [Related]
38. Semaphorin-3F functions as a tumor suppressor in colorectal cancer due to regulation by DNA methylation.
Gao X; Tang C; Shi W; Feng S; Qin W; Jiang T; Sun Y
Int J Clin Exp Pathol; 2015; 8(10):12766-74. PubMed ID: 26722466
[TBL] [Abstract][Full Text] [Related]
39. Methylation of SLFN11 is a marker of poor prognosis and cisplatin resistance in colorectal cancer.
He T; Zhang M; Zheng R; Zheng S; Linghu E; Herman JG; Guo M
Epigenomics; 2017 Jun; 9(6):849-862. PubMed ID: 28403629
[TBL] [Abstract][Full Text] [Related]
40. Deoxyshikonin isolated from
Zhu Y; Zhong Y; Long X; Zhu Z; Zhou Y; Ye H; Zeng X; Zheng X
Pharm Biol; 2019 Dec; 57(1):412-423. PubMed ID: 31230505
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]